Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

$ALLOPress releaseAug 4, 2026, 8:30 AM ETRead the release

Allogene Therapeutics announced it will report its second quarter 2026 financial results and provide a business update on August 12, 2026, after the market close. The company will host a live audio webcast and conference call at 2:00 p.m. PT/5:00 p.m. ET on the same day to discuss the results.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.